Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

support pharma, s.l. - marbofloxacin - solution for injection - 40 mg/ml - antibacterial - porcine

Ujerumani - Kiingereza - HMA (Heads of Medicines Agencies)

norbrook laboratories limited - marbofloxacin 0 % - injection - cattle - marbofloxacin

Marekani - Kiingereza - NLM (National Library of Medicine)

dechra veterinary products llc - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - indications and usage: marboquin (marbofloxacin) tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. contraindications: marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

Marekani - Kiingereza - NLM (National Library of Medicine)

aspen veterinary resources®, ltd - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - delaquintm  chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

Marekani - Kiingereza - NLM (National Library of Medicine)

mwi - marbofloxacin (unii: 8x09wu898t) (marbofloxacin - unii:8x09wu898t) - fluoroflox chewable tablets are indicated for the treatment of infections in dogs and cats associated with bacteria susceptible to marbofloxacin. marbofloxacin and other quinolones have been shown to cause arthropathy in immature animals of most species tested, the dog being particularly sensitive to this side effect. marbofloxacin is contraindicated in immature dogs during the rapid growth phase (small and medium breeds up to 8 months of age, large breeds up to 12 months of age and giant breeds up to 18 months of age). marbofloxacin is contraindicated in cats under 12 months of age. marbofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones.

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - marbofloxacin - solution for injection - 20 milligram(s)/millilitre - marbofloxacin - cats, cattle, dogs, pigs - antibacterial

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

emdoka - marbofloxacin - tablet - 20 mg/tablet - marbofloxacin - canine - antibacterial

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

emdoka - marbofloxacin - tablet - 5 mg/tablet - marbofloxacin - canine, feline - antibacterial

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

emdoka - marbofloxacin - tablet - 80 mg/tablet - marbofloxacin - canine - antibacterial

Ayalandi - Kiingereza - HPRA (Health Products Regulatory Authority)

vetoquinol ireland limited - marbofloxacin - solution for injection - 100 milligram(s)/millilitre - marbofloxacin - cattle, pigs - antibacterial